Paul Matthews, OBE, MD, DPhil, FRCP, FMedSci is the Edmond and Lily Safra Chair and Head of the new Division of Brain Sciences in the Department of Medicine of Imperial College, London, UK.
Professor Matthews' research is noted for innovative translational applications of clinical imaging for the neurosciences. He was the founding director of two internationally leading research imaging centres: the University of Oxford Centre for Functional Magnetic Resonance Imaging of the Brain (FMRIB) and, later, of GlaxoSmithKline’s Clinical Imaging Centre. From 2005 to 2014 he was the Vice President of GlaxoSmithKline Medicines Discovery and Development. An overarching application of his work with clinical tools for experimental clinical neuroscience drug development has been to address the challenge of neurodegeneration in MS and enhancing intrinsic brain repair and plasticity for functional recovery.
He is an NIHR senior investigator and Chair of the Imaging Working Group for UK Biobank and the Dementias Platforms UK Imaging Network.
Support from the Edmond J. Safra Foundation and Lily Safra, the ICHT BRC, the Prog MS Alliance, the MS Society and the MRC and his work has generated honoraria or research support for his Division from GlaxoSmithKline, Biogen, Novartis, Adelphi Communications, IXICO and Transparency Life Sciences.